Related Experiment Video

Updated: Dec 6, 2025

Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR
08:01

Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR

Published on: November 27, 2019

7.8K

The First Case of an HIV Patient Diagnosed with COVID-19 in Korea

Ji Yeon Kim1, Jong Myoung Kim2, Kyong Ran Peck3

  • 1Division of Infectious Disease, Department of Medicine, Seongnam Citizens Medical Center, Seongnam, Korea.

Journal of Korean Medical Science
|October 12, 2020
PubMed

Insights

This case study shows a well-controlled human immunodeficiency virus (HIV) patient recovering from coronavirus disease 2019 (COVID-19). Controlled HIV infection did not appear to worsen COVID-19 prognosis in this patient.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Comorbidities like diabetes, lung, and kidney disease are known COVID-19 risk factors.
  • The prognosis for human immunodeficiency virus (HIV) patients with COVID-19 remains unclear.
  • Over 11,000 COVID-19 cases and 13,000 people living with HIV were reported in Korea by May 2020.

Observation:

  • The first reported case of a COVID-19 patient with HIV in Korea.
  • A 29-year-old male with well-controlled HIV (CD4 count 555/mm³) on Genvoya® presented with mild COVID-19 symptoms.
  • Pneumonia observed on chest CT improved without supplemental oxygen.

Findings:

  • The patient experienced mild symptoms including sore throat, cough, and loss of taste/smell.
  • Treatment included hydroxychloroquine with continued Genvoya®.
  • The patient was discharged on hospital day 31 with improved pneumonia.

Implications:

  • Despite being considered immunocompromised, well-controlled HIV patients may have a satisfactory prognosis for COVID-19.
  • This case highlights the importance of proper medical care for HIV patients with COVID-19.
  • Further research is needed to understand COVID-19 outcomes in the HIV population.

Keywords:
COVID-19HIVSARS-CoV-2

More Related Videos

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.9K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
673
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.6K